XML 65 R50.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes - Schedule of Gross Deferred Tax Asset and Related Valuation Allowance (Detail) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Deferred income tax assets:    
Net operating loss carryforward $ 79,788,146 $ 63,830,866
Capitalized start-up costs 920,516 1,114,309
Patent amortization 73,480 88,949
Research and orphan drug credits 47,976,370 42,008,797
Stock-based compensation 7,102,947 6,778,569
Operating lease liabilities 528,340 775,598
Accrued bonus 592,260 919,410
Other 209,580 283,751
Gross deferred income tax assets 137,191,639 115,800,249
Valuation allowance (136,613,829) (115,016,323)
Net deferred income tax assets 577,810 783,926
Deferred tax liabilities:    
Operating lease right-of-use assets (433,727) (639,843)
Property and equipment (144,083) (144,083)
Gross deferred income tax liabilities (577,810) (783,926)
Net deferred income tax asset/(liability)